Euromed Pharma offers support for every clinical and non-clinical phase of the development of the drug, from the acquisition of samples for non-human use, to the supply of drugs for the phases III and IV of the Clinical Study.
Euromed Pharma acts as a precious link between the AIC representative and the patients when the latters are in need of drugs, most of the times “life-saving” treatments for incurable diseases, that can’t be made available in the common clinical or commercial context.
Help us make a difference on a global scale. Whether you are starting or continuing your career, find out how to express your talent in Petrone to have an impact on the world from Italy.
Raffaele Petrone
Petrone Group CEO